OTLK
Price
$1.71
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
76.28M
PDSB
Price
$1.33
Change
+$0.06 (+4.72%)
Updated
Jul 3 closing price
Capitalization
60.79M
39 days until earnings call
Interact to see
Advertisement

OTLK vs PDSB

Header iconOTLK vs PDSB Comparison
Open Charts OTLK vs PDSBBanner chart's image
Outlook Therapeutics
Price$1.71
Change-$0.00 (-0.00%)
Volume$946
Capitalization76.28M
PDS Biotechnology
Price$1.33
Change+$0.06 (+4.72%)
Volume$141.46K
Capitalization60.79M
OTLK vs PDSB Comparison Chart in %
Loading...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OTLK vs. PDSB commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTLK is a StrongBuy and PDSB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (OTLK: $1.71 vs. PDSB: $1.33)
Brand notoriety: OTLK and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OTLK: 0% vs. PDSB: 24%
Market capitalization -- OTLK: $76.28M vs. PDSB: $60.79M
OTLK [@Biotechnology] is valued at $76.28M. PDSB’s [@Biotechnology] market capitalization is $60.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OTLK’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • OTLK’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, PDSB is a better buy in the long-term than OTLK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OTLK’s TA Score shows that 6 TA indicator(s) are bullish while PDSB’s TA Score has 5 bullish TA indicator(s).

  • OTLK’s TA Score: 6 bullish, 2 bearish.
  • PDSB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OTLK is a better buy in the short-term than PDSB.

Price Growth

OTLK (@Biotechnology) experienced а -2.29% price change this week, while PDSB (@Biotechnology) price change was -8.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

OTLK is expected to report earnings on May 15, 2025.

PDSB is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLK($76.3M) has a higher market cap than PDSB($60.8M). OTLK YTD gains are higher at: -9.524 vs. PDSB (-18.405). PDSB has higher annual earnings (EBITDA): -33.08M vs. OTLK (-76.83M). PDSB has more cash in the bank: 40M vs. OTLK (7.56M). PDSB has less debt than OTLK: PDSB (19M) vs OTLK (33.3M). OTLK (0) and PDSB (0) have equivalent revenues.
OTLKPDSBOTLK / PDSB
Capitalization76.3M60.8M125%
EBITDA-76.83M-33.08M232%
Gain YTD-9.524-18.40552%
P/E Ratio0.44N/A-
Revenue00-
Total Cash7.56M40M19%
Total Debt33.3M19M175%
FUNDAMENTALS RATINGS
OTLK vs PDSB: Fundamental Ratings
OTLK
PDSB
OUTLOOK RATING
1..100
6682
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
n/a32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for OTLK (85) in the Biotechnology industry. This means that PDSB’s stock grew somewhat faster than OTLK’s over the last 12 months.

PDSB's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as OTLK (100) in the Biotechnology industry. This means that PDSB’s stock grew similarly to OTLK’s over the last 12 months.

PDSB's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as OTLK (100) in the Biotechnology industry. This means that PDSB’s stock grew similarly to OTLK’s over the last 12 months.

OTLK's Price Growth Rating (61) in the Biotechnology industry is in the same range as PDSB (63) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew similarly to PDSB’s over the last 12 months.

OTLK's P/E Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for PDSB (100) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew somewhat faster than PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OTLKPDSB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YNNHF1.70N/A
N/A
Yihai Intl Hldg Ltd.
CCHBF52.24N/A
N/A
COCA COLA HBC LTD
DCOHF0.56N/A
N/A
Dickson Concepts International Ltd.
CLYYF0.50N/A
N/A
Celyad Oncology SA
FNMAK22.11N/A
N/A
Fannie Mae

OTLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with CYTK. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
N/A
CYTK - OTLK
33%
Loosely correlated
+0.87%
PDSB - OTLK
33%
Loosely correlated
+4.72%
MCRB - OTLK
32%
Poorly correlated
+9.30%
VIR - OTLK
31%
Poorly correlated
-0.37%
ALXO - OTLK
30%
Poorly correlated
+3.39%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with ARCT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+4.72%
ARCT - PDSB
49%
Loosely correlated
+1.17%
RXRX - PDSB
48%
Loosely correlated
+1.15%
DYN - PDSB
45%
Loosely correlated
-2.01%
ATOS - PDSB
45%
Loosely correlated
+1.43%
NRIX - PDSB
44%
Loosely correlated
+2.33%
More